Redfaces
Pardon my ignorance, I am also new to this,and i am quite happy to stand corrected but I am trying to reconcile your 1000 patients required for the trial, to that of the prof who said that orphan status can be granted to a company developing a drug treatment for a disease with only small prevalence in the population.
So if there is a small prevalance in the population, will the FDA accept less than the "several hundred to several thousand "
I acknowledge that a small prevalence in the USA may still be a large number.
Thanks in anticipation
RedfacesPardon my ignorance, I am also new to this,and i am...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.005(1.27%) |
Mkt cap ! $569.8M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 39.0¢ | $1.746M | 4.422M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7395 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 94636 | 3 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |